Search Results - "Roh, Tae Chul"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    KL1333, a Novel NAD + Modulator, Improves Energy Metabolism and Mitochondrial Dysfunction in MELAS Fibroblasts

    KL1333, a Novel NAD + Modulator, Improves Energy Metabolism and Mitochondrial Dysfunction in MELAS Fibroblasts by Seo, Kang-Sik, Kim, Jin-Hwan, Min, Ki-Nam, Moon, Jeong-A, Roh, Tae-Chul, Lee, Mi-Jung, Lee, Kang-Woo, Min, Ji-Eun, Lee, Young-Mock

    Published in Frontiers in neurology (05-07-2018)
    “…Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), one of the most common maternally inherited mitochondrial diseases, is…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Abstract 2697: YPN005, an oral CDK7 inhibitor, exhibits a significant antitumor activity in Myc-driven cancers

    Abstract 2697: YPN005, an oral CDK7 inhibitor, exhibits a significant antitumor activity in Myc-driven cancers by Lee, Kwang-Ok, Yoo, Jakyung, Lee, Mi Jung, Lee, Kang Woo, Min, Ji Eun, Kim, Jinhwan, Min, Ki-Nam, Roh, Tae Chul, Seo, Kang-Sik, Rhee, Hae In, Lee, Jun Hee, Jeon, Da-Hye, Lim, Dae Seong

    Published in Cancer research (Chicago, Ill.) (01-07-2019)
    “…Background: CDK7 plays an important role in regulating cell cycle progression and gene via activation of cell cycle kinases (CDK1, CDK2, CDK4 and CDK6) and RNA…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: